SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-214587
Filing Date
2019-08-07
Accepted
2019-08-07 07:08:34
Documents
4
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d751587d8k.htm 8-K 18833
2 EX-99.1 d751587dex991.htm EX-99.1 588145
3 EX-99.2 d751587dex992.htm EX-99.2 206459
4 GRAPHIC g751587page1a.jpg GRAPHIC 2621
  Complete submission text file 0001193125-19-214587.txt   818554
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 191003806
SIC: 2834 Pharmaceutical Preparations